National Health Investors (NYSE:NHI) Price Target Raised to $76.00
National Health Investors (NYSE:NHI – Free Report) had its price objective increased by Truist Financial from $70.00 to $76.00 in a research report report published on Wednesday,Benzinga reports. The brokerage currently has a hold rating on the real estate investment trust’s stock. Separately, Wedbush restated an “outperform” rating and set a $88.00 price target on […]
National Health Investors (NYSE:NHI – Free Report) had its price objective increased by Truist Financial from $70.00 to $76.00 in a research report report published on Wednesday,Benzinga reports. The brokerage currently has a hold rating on the real estate investment trust’s stock. Separately, Wedbush restated an “outperform” rating and set a $88.00 price target on […]
